Notably, a recent study in 2023 by Guszcz [21] explored these compounds in the context of bladder cancer, reporting that plasma fibronectin concentrations ranged from 176 to 627 μg mL−1, with a median of 473 μg mL−1. This evidence concerns the gene FN1 and urinary bladder carcinoma.